FIELD: medicine.
SUBSTANCE: invention is a method for prediction of comorbid anxious disorder in patients with recurrent depressive disorder, characterized by determination of cortisol and dehydroepiandrosterone sulfate (DHEAS) neurosteroid content in the blood, as well as phagocytal activity of leukocytes, and at cortisol concentrations above 850 nmol/l, ratio of DHEAS/cortisol below 3.5 and phagocytal index below 55%, comorbid anxious disorder is predicted in patients with recurrent depressive disorder.
EFFECT: possibility of prediction of comorbid anxious disorder in patients with recurrent depressive disorder.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN DEPRESSIVE EPISODE | 2013 |
|
RU2530635C1 |
| METHOD FOR PREDICTION OF EFFICACY OF LADASTEN THERAPY OF ORGANIC ASTHENIC DISORDERS | 2011 |
|
RU2459208C1 |
| METHOD FOR ASSESSING SEVERITY OF CURRENT DEPRESSIVE EPISODE IN PATIENTS WITH RECURRENT DEPRESSIVE DISORDER | 2013 |
|
RU2540491C1 |
| METHOD FOR ASSESSING SEVERITY OF A CURRENT DEPRESSIVE EPISODE IN COMORBIDITY OF AFFECTIVE AND PERSONALITY DISORDERS | 2015 |
|
RU2599975C1 |
| METHOD FOR ASSESSING THE RISK OF SUICIDAL BEHAVIOR OF PATIENTS WITH BIPOLAR AFFECTIVE DISORDER | 2019 |
|
RU2726470C1 |
| METHOD FOR PREDICTION OF COMORBID COURSE OF AFFECTIVE DISORDERS AND ALCOHOLISM BASED ON DETERMINATION OF BLOOD SERUM PROTEINS | 2021 |
|
RU2767699C1 |
| METHOD OF PROGNOSIS OF CLINIC COURSE OF NEUROTIC DISORDERS | 2007 |
|
RU2356059C1 |
| METHOD OF THE PANIC DISORDER FORMING RISK PREDICTING AT THE EARLY STAGE OF DISEASE | 2016 |
|
RU2644309C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PANIC DISORDER AND ORGANIC ANXIOUS DISORDER IN CONNECTION WITH VASCULAR DISEASE OF THE BRAIN | 2021 |
|
RU2770734C1 |
| METHOD FOR PREDICTION OF COURSE OF ADAPTATION DISORDER | 2019 |
|
RU2717307C1 |
